Stem cell patent indicates support for regenerative medicine research

24-03-2014

Stem cell patent indicates support for regenerative medicine research

Illustration: Spectral-Design / Shutterstock.com

The US Patent and Trademark Office has issued a patent to Israeli biotechnology company BrainStorm Cell Therapeutics, which covers stem cell technology that can be used in the treatment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s.


Stem cells, BrainStorm Cell Therapeutics, USPTO, Parkinson’s, Alzheimer’s

LSIPR